ID
37324
Beschrijving
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This 12 lead ECG form is to be completed at Screening, Day 2/3/4 at 0 hrs for all cohorts (Day 4 0 hrs denoted as Day 3 24 hrs), Follow-Up and for any repeat/unscheduled ECGs.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Trefwoorden
Versies (1)
- 17-07-19 17-07-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
17 juli 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
SB-681323 in ALI/ARDS risk patients - NCT00996840
12 Lead ECG
- StudyEvent: ODM
Beschrijving
Dosing Date and Time
Alias
- UMLS CUI-1
- C3897500
- UMLS CUI-2
- C3469597
- UMLS CUI-3
- C0304229
Beschrijving
ECG
Alias
- UMLS CUI-1
- C1623258
Beschrijving
only applicable for scheduled ECGs on Day 2 (0 hrs) and Day 3 (0 hrs, 24 hrs)
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0439564
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C3897500
- UMLS CUI [1,4]
- C3469597
- UMLS CUI [1,5]
- C0304229
Beschrijving
ECG Date / Time
Datatype
datetime
Alias
- UMLS CUI [1]
- C2826846
Beschrijving
Heart Rate
Datatype
integer
Maateenheden
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Beschrijving
PR Interval
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1]
- C0429087
Beschrijving
QRS Duration
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1]
- C0429025
Beschrijving
Uncorrected QT Interval
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1,1]
- C1287082
- UMLS CUI [1,2]
- C4072785
Beschrijving
If Machine -> record the QTC values(s) generated by the machine (QTcF/QTcB) If Manual -> record the RR interval that precedes the measured QT interval
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C2911685
Beschrijving
if applicable
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1,1]
- C1882512
- UMLS CUI [1,2]
- C0855331
Beschrijving
if applicable
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1,1]
- C0855331
- UMLS CUI [1,2]
- C1882513
Beschrijving
if applicable
Datatype
float
Maateenheden
- msec
Alias
- UMLS CUI [1,1]
- C0489636
- UMLS CUI [1,2]
- C0332152
- UMLS CUI [1,3]
- C0855331
Beschrijving
if 3 = Abnormal - Clinically significant: complete the ECG abnormality form for all clinically significant abnormalities, and additionally complete the AE form if the abnormality meets the protocol definition for an AE
Datatype
integer
Alias
- UMLS CUI [1]
- C0438154
Similar models
12 Lead ECG
- StudyEvent: ODM
C3469597 (UMLS CUI-2)
C0304229 (UMLS CUI-3)
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0687676 (UMLS CUI [1,2])
C3897500 (UMLS CUI [1,3])
C3469597 (UMLS CUI [1,4])
C0304229 (UMLS CUI [1,5])
C4072785 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,2])
C1882513 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,2])
C0855331 (UMLS CUI [1,3])
Geen commentaren